<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T04:08:35Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/12653" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/12653</identifier><datestamp>2025-10-24T10:35:41Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Extended sequential intravenous and oral antimicrobial therapy improves cure rate in postoperative intracranial neurosurgical infections: a Spanish multicenter retrospective study</dc:title>
   <dc:creator>Asensi, Víctor</dc:creator>
   <dc:creator>Vázquez Fernández, Carlos</dc:creator>
   <dc:creator>Suárez-Díaz, Silvia</dc:creator>
   <dc:creator>Asensi-Díaz, Elia</dc:creator>
   <dc:creator>Carrasco-Antón, Nerea</dc:creator>
   <dc:creator>García-Reyne, Ana</dc:creator>
   <dc:creator>biosca, mercedes</dc:creator>
   <dc:subject>Medicació oral</dc:subject>
   <dc:subject>Teràpia intravenosa</dc:subject>
   <dc:subject>Medicaments antiinfecciosos - Ús terapèutic</dc:subject>
   <dc:subject>Sistema nerviós - Cirurgia</dc:subject>
   <dc:subject>Infeccions quirúrgiques</dc:subject>
   <dc:subject>DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Postoperative Complications::Surgical Wound Infection</dc:subject>
   <dc:subject>DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Postoperative Complications</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Neurosurgical Procedures</dc:subject>
   <dc:subject>CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/therapeutic use</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Drug Therapy::Drug Administration Routes::Administration, Oral</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Drug Therapy::Drug Administration Routes::Administration, Intravenous</dc:subject>
   <dc:subject>ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::complicaciones posoperatorias::infección de la herida quirúrgica</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos neuroquirúrgicos</dc:subject>
   <dc:subject>COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/uso terapéutico</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::farmacoterapia::vías de administración de medicamentos::administración oral</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::farmacoterapia::vías de administración de medicamentos::administración intravenosa</dc:subject>
   <dc:subject>ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::complicaciones posoperatorias</dc:subject>
   <dcterms:abstract>Antimicrobial therapy; Intracranial infections; Neurosurgery</dcterms:abstract>
   <dcterms:abstract>Terapia antimicrobiana; Infecciones intracraneales; Neurocirugía</dcterms:abstract>
   <dcterms:abstract>Teràpia antimicrobiana; Infeccions intracranials; Neurocirurgia</dcterms:abstract>
   <dcterms:abstract>Background&#xd;
Postoperative intracranial neurosurgical infections (PINI) complicate &lt; 5% neurosurgeries. Scarce attention was dedicated to the extension and characteristics of its antimicrobial management considering their high morbidity, not negligible mortality, delayed hospital stay and increased healthcare costs.&#xd;
Methods&#xd;
We analyzed retrospectively (2014–2023) 162 PINI from eight Spanish third-level academic hospitals.&#xd;
Results&#xd;
Elective clean craniotomies after tumor or vascular causes were the leading procedures. Epidural abscess (24.7%), scalp infections (19.8%), postsurgical meningitis (16.7%) and cranioplasty infections (16.7%) were the most frequent PINI. Gram negative bacteria (38.6%) and Staphylococcus spp (28.6%) were the predominant isolates. Overall 85.2% patients underwent pus drainage, mostly by craniotomy (40.3%). Interestingly 34% were already receiving antibiotics for extracranial infections before developing PINI while 16.8% did not receive pre-operative antibiotic prophylaxis. In total 77.2% patients started a combined intravenous (IV) antimicrobial therapy, of which 85.2% switched after 5 days to a second-line IV antibiotic regimen, in 41.3% cases combined, after pus culture results, for a median of 21 days. Overall 61.1% patients continued on oral antimicrobials after hospital discharge, 30.3% as a combined regimen, for a median of 42 days. Complete cure was obtained in 81.5% cases, while 11.1% relapsed, 7.4% failed to cure and 6.8% died after PINI complications. In the multivariate analysis oral antimicrobial therapy after hospital discharge (p = 0.001) was significantly associated with PINI cure with no effect on survival.&#xd;
Conclusions&#xd;
We conclude that an extended 6 weeks sequential IV and oral antimicrobial therapy in addition to neurosurgical correction increases PINI cure rate with no effect on survival.&#xd;
Clinical trial number&#xd;
Not applicable.</dcterms:abstract>
   <dcterms:abstract>The Infectious Diseases Working Group of the Spanish Society of Internal Medicine (SEMI) supported and funded this study.</dcterms:abstract>
   <dcterms:dateAccepted>2025-10-24T10:35:41Z</dcterms:dateAccepted>
   <dcterms:available>2025-10-24T10:35:41Z</dcterms:available>
   <dcterms:created>2025-10-24T10:35:41Z</dcterms:created>
   <dcterms:issued>2025-02-26T08:16:49Z</dcterms:issued>
   <dcterms:issued>2025-02-26T08:16:49Z</dcterms:issued>
   <dcterms:issued>2024-11-26</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>http://hdl.handle.net/11351/12653</dc:identifier>
   <dc:relation>BMC Infectious Diseases;24</dc:relation>
   <dc:relation>https://doi.org/10.1186/s12879-024-10204-7</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>BMC</dc:publisher>
   <dc:source>Scientia</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>